TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/03/2025
Back to search
Official data from USPTO
CHROMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
09/11/2025
Trademark type
Word
Nice classes
9, 42
Filing date
08/02/2023
Registration date
11/12/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/12/2024
Last transaction
09/11/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/15/2023
First use in commerce
11/15/2023
Drawing code
4
Owner type
03
Owner location
Somerville, MA
Examiner
GUROK, GALINA
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Generate Biomedicines, Inc.
Generate Biomedicines, Inc.
Representatives
Jennifer M. Mikulina McDermott Will & Schulte LLP
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software for use in the pharmaceuticals and healthcare fieldsfor molecular researchresearch and development of pharmaceutical products and chemical compoundsdesign of chemical structuresanalysis of biological or chemical activity; downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields for molecular researchresearch and development of pharmaceutical products and chemical compoundsdesign of chemical structuresanalysis of biological or chemical activity in connection with pharmaceutical drug discovery and development; downloadable artificial intelligence software for use in the field of healthcare for molecular researchresearch and development of pharmaceutical products and chemical compoundsdesign of chemical structuresanalysis of biological or chemical activity
Class 42
Researchdevelopmentdesign of pharmaceuticals and medicines for others; scientific research in the field of pharmaceutical and medicine designdiscovery and development services for others; research and development of technology for others in the field of pharmaceuticals; research and development of technology for others in the field of computational biology; pharmaceuticalmedicalscientificbiotechnologybiopharmaceutical research and development for others; collecting and analyzing complex biological data through the use of artificial intelligencedata automation and collection service using proprietary software to evaluateanalyze and collect biological data; computer assisted molecule design involving the use of artificial intelligence technologyproduct design and development in the field of medicine; conducting scientific and pharmaceutical artificial intelligence research services for others to identify molecules and compounds for drug developmentscientific research in the field of pharmaceuticals; providing online non-downloadable computer software for use in the pharmaceuticals and healthcare fieldsfor molecular researchresearch and development of pharmaceutical products and chemical compoundscell analysisdesign of chemical structuresanalysis of biological or chemical activity; providing online non-downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fieldsfor diagnostic and therapeutic usefor data mining in connection with pharmaceutical drug discoverydrug developmentpharmaceutical market accesschemogenomicstoxicogenomics and drug response prediction; providing online non-downloadable self-learning and artificial intelligence software for use in the field of healthcare for molecular researchresearch and development of pharmaceutical products and chemical compoundscell analysisdesign of chemical structuresanalysis of biological or chemical activity; providing online non-downloadable software using artificial intelligence for use in the biotechnology field for discovering and designing biomolecules
Publications
History of USPTO decisions and trademark events.
28 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/03/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/03/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/03/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/03/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/27/2024
PUBO
PUBLISHED FOR OPPOSITION
08/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/03/2024
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
04/11/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/10/2024
GNRT
NON-FINAL ACTION E-MAILED
04/10/2024
CNRT
NON-FINAL ACTION WRITTEN
04/10/2024
IUAA
USE AMENDMENT ACCEPTED
04/10/2024
DOCK
ASSIGNED TO EXAMINER
04/03/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
12/12/2023
IUAF
USE AMENDMENT FILED
12/12/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
12/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/31/2023
NWAP
NEW APPLICATION ENTERED
08/05/2023
Continuous trademark protection
Get notified about every new filing that threatens CHROMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.